Article thumbnail

Multifocal Electroretinogram Findings after Intravitreal Bevacizumab Injection in Choroidal Neovascularization of Age-Related Macular Degeneration

By Joo Youn Park, Seung Hoon Kim, Tae Kwann Park and Young-Hoon Ohn
Topics: Original Article
Publisher: The Korean Ophthalmological Society
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2009). A systematic review on the effect of bevacizumab in exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol
  2. Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia.
  3. Assessing retinal function with the multifocal technique.
  4. (1998). Assessment of local retinal function in patients with retinitis pigmentosa using the multi-focal ERG technique. Vision Res
  5. (1995). Clinical evaluation of multifocal electroretinogram.
  6. Comparison of mfERG waveform components and implicit time measurement techniques for detecting functional change in early diabetic eye disease.
  7. Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization.
  8. Effects and prognostic factors of intravitreal bevacizumab injection on choroidal neovascularization from age-related macular degeneration.
  9. Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatment.
  10. Electrophysiological effects of intravitreal Avastin (bevacizumab) in the treatment of exudative age-related macular degeneration.
  11. (1999). Familial macular cone dystrophy: diagnostic value of multifocal ERG and two-color threshold perimetry. Graefes Arch Clin Exp Ophthalmol
  12. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
  13. (2009). Intravitreal injection of 2.5 mg versus 1.25 mg bevacizumab (Avastin) for treatment of CNV associated with AMD. Retina
  14. Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT study. Multifocal-ERG after use of bevacizumab in ARMD.
  15. Long-term effect of intravitreal bevacizumab for CNV secondary to age-related macular degeneration.
  16. (2003). Multifocal electroretinography and its clinical application.
  17. (1998). Multifocal electroretinography in retinitis pigmentosa.
  18. (1996). Occult macular dystrophy.
  19. Prevalence of age-related macular degeneration in the United States.
  20. Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration.
  21. Retinal origins of the primate multifocal ERG: implications for the human response.
  22. (2006). Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina
  23. The electroretinogram: a useful tool for evaluating age-related macular disease?
  24. The multifocal electroretinogram.
  25. The role of vascular endothelial growth factor in ocular health and disease.
  26. (1999). Topography of cone electrophysiology in the enhanced S cone syndrome. Invest Ophthalmol Vis Sci
  27. Vascular endothelial growth factor: basic science and clinical progress.
  28. Which treatment is best for which AMD patient?